Effect of Tanshinone IIA on the Noncovalent Interaction Between Warfarin and Human Serum Albumin Studied by Electrospray Ionization Mass Spectrometry

Journal of the American Society for Mass Spectrometry

Volumn 19, Issue 10, 2008, Pages 1568-1575

  Liu, Jie ^a   Wang, Xiaoru ^a,c   Cai, Zongwei ^b   Lee, Frank S C ^c  

^a XIAMEN UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c FIRST INSTITUTE OF OCEANOGRAPHY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOCHEMISTRY; BLOOD; BODY FLUIDS; CONCENTRATION (PROCESS); DRUG INTERACTIONS; FLOW INTERACTIONS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; IONIZATION OF LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; MEDICINE; METABOLISM; OFFSHORE OIL WELL PRODUCTION; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; WATER ANALYSIS;

ACTIVE COMPONENTS; ANTI-COAGULATION; ELECTRO SPRAYING; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; ELEVATED LEVELS; EXPERIMENTAL APPROACHES; HUMAN SERUM ALBUMIN; IN-VITRO; IN-VIVO; ION TRAP-MASS SPECTROMETRY; METABOLIC RATES; NON-COVALENT INTERACTIONS; SPECTROMETRIC TECHNIQUES; TANSHINON; TANSHINONE II A; TIME -OF-FLIGHT; TRADITIONAL CHINESE MEDICINE;

ELECTROSPRAY IONIZATION;

DRUG METABOLITE; HUMAN SERUM ALBUMIN; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HERB DRUG INTERACTION; ION TRAP MASS SPECTROMETRY; LIPID SOLUBILITY; MALE; METABOLIC RATE; NONHUMAN; RAT; SALVIA MILTIORRHIZA; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BINDING, COMPETITIVE; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; HUMANS; MALE; PHENANTHRENES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; WARFARIN;

RATTUS;

EID: 53349129384     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2008.06.005     Document Type: Article

References (47)

1. Chinese Pharmacopoeia. Part 1. Chemical Industry Press: Beijing, 2005; pp 52-53.
2. Cai Z., Lee F.S.C., Wang X.R., and Yu W.J. A Capsule Review of Recent Studies on the Application of Mass Spectrometry in the Analysis of Chinese Medicinal Herbs. J. Mass Spectrom. 37 (2002) 1013-1024
3. Wang X., Morris-Natschke S.L., and Lee K.H. New Developments in the Chemistry and Biology of the Bioactive Constituents of Tanshen. Med. Res. Rev. 27 (2007) 133-148
4. Naidong W., Ring P.R., Midtlien C., and Jiang X. Development and Validation of a Sensitive and Robust LC-Tandem MS Method for the Analysis of Warfarin Enantiomers in Human Plasma. J. Pharm. Biomed. Anal. 25 (2001) 219-226
5. Kaminsky L.S., and Zhang Z.Y. Human P450 Metabolism of Warfarin. Pharmacol. Ther. 73 (1997) 67-74
6. Izzo A.A., Di Carlo G., Borrelli F., and Ernst E. Cardiovascular Pharmacotherapy and Herbal Medicines: The Risk of Drug Interaction. Int. J. Cardiol. 98 (2005) 1-14
7. Zhou L., Zuo Z., and Chow M.S.S. Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use. J. Clin. Pharmacol. 45 (2005) 1345-1359
8. Yu C.M., Chan J.C.N., and Sanderson J.E. Chinese Herbs and Warfarin Potentiation by "Danshen.". J. Intern. Med. 241 (1997) 337-339
9. Fugh-Berman A. Herb-Drug Interactions. Lancet 355 (2000) 134-138
10. Heck A.M., Dewitt B.A., and Lukes A.L. Potential Interactions between Alternative Therapies and Warfarin. Am. J. Health-Syst. Pharm. 57 (2000) 1221-1227
11. Hu Z., Yang X., Ho P.C.L., Chan S.Y., Heng P.W.S., Chan E., Duan W., Koh H.L., and Zhou S. Herb-Drug Interactions. Drugs 65 (2005) 1239-1282
12. Mahesha H.G., Singh S.A., Srinivasan N., and Appu Rao A.G. A Spectroscopic Study of the Interaction of Isoflavones with Human Serum Albumin. FEBS J. 273 (2006) 451-467
13. Tang J., Luan F., and Chen X. Binding Analysis of Glycyrrhetinic Acid to Human Serum Albumin: Fluorescence Spectroscopy, FTIR, and Molecular Modeling. Bioorg. Med. Chem. 14 (2006) 3210-3217
14. Li Y., He W., Liu J., Sheng F., Hu Z., and Chen X. Binding of the Bioactive Component Jatrorrhizine to Human Serum Albumin. Biochim. Biophys. Acta 1722 (2005) 15-21
15. Qin C., Xie M., and Liu Y. Characterization of the Myricetin-Human Serum Albumin Complex by Spectroscopic and Molecular Modeling Approaches. Biomacromolecules 8 (2007) 2182-2189
16. Li Y., He W.Y., Liu H., Yao X., and Hu Z. Daidzein Interaction with Human Serum Albumin Studied Using Optical Spectroscopy and Molecular Modeling Methods. J. Mol. Struct. 831 (2007) 144-150
17. Dufour C., and Dangles O. Flavonoid-Serum Albumin Complexation: Determination of Binding Constants and Binding Sites by Fluorescence Spectroscopy. Biochim. Biophys. Acta 1721 (2005) 164-173
18. Jin J., Zhu J., Yao X., and Wu L. Study on the Binding of Farrerol to Human Serum Albumin. J. Photochem. Photobiol. A: Chemistry 191 (2007) 59-65
19. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., and Curry S. Structural Basis of the Drug-Binding Specificity of Human Serum Albumin. J. Mol. Biol. 353 (2005) 38-52
20. Ascenzi P., Bocedi A., Notari S., Fanali G., Fesce R., and Fasano M. Allosteric Modulation of Drug Binding to Human Serum Albumin. Mini-Rev. Med. Chem. 6 (2006) 483-489
21. Gupta D., Jalali M., Wells A., and Dasgupta A. Drug-Herb Interactions: Unexpected Suppression of Free Danshen Concentrations by Salicylate. J. Clin. Lab. Anal. 16 (2002) 290-294
22. Zhang L.W., Yang P., and Wang F. Spectroscopic Studies on the Binding of Effective Component of Chinese Herbs with Human Serum Albumin. Spectrosc. Spectral. Anal. 21 (2001) 694-696
23. Xie M.X., Xu X.Y., Wang Y.D., and Liu Y. Spectroscopic Investigation of the Interaction between 2,3-Dihydro-4′,5,7-trihydroxyflavone and Human Serum Albumin. Acta Chim. Sinica 63 (2005) 2055-2062
24. 19F NMR Spectroscopy: Proof of Concept. Angew. Chem. Int. Ed. 45 (2006) 3450-3453
25. Kaiser M., Groll M., Siciliano C., Assfalg-Machleidt I., Weyher E., Kohno J., Milbradt A.G., Renner C., Huber R., and Moroder L. Binding Mode of TMC-95A Analogues to Eukaryotic 20S Proteasome. ChemBioChem 5 (2004) 1256-1266
26. Loo J.A. Studying Noncovalent Protein Complexes by Electrospray Ionization Mass Spectrometry. Mass Spectrom. Rev. 16 (1997) 1-23
27. Huang E.C., Pramanik B.N., Tsarbopoulos A., Reichert P., Ganguly A.K., Trotta P.P., Nagabhushan T.L., and Covey T.R. Application of Electrospray Mass Spectrometry in Probing Protein-Protein and Protein-Ligand Noncovalent Interactions. J. Am. Soc. Mass Spectrom. 4 (1993) 624-630
28. Bazoti F.N., Markides K.E., Bergquist J., and Tsarbopoulos A. Noncovalent Interaction Between Amyloid-β-peptide (1-40) and Oleuropein Studied by Electrospray Ionization Mass Spectrometry. J. Am. Soc. Mass Spectrom. 17 (2006) 568-575
29. Heck A.J.R., and van den Heuvel R.H.H. Investigation of Intact Protein Complexes by Mass Spectrometry. Mass Spectrom. Rev. 23 (2004) 368-389
30. Ashcroft A.E. Recent Developments in Electrospray Ionisation Mass Spectrometry: Noncovalently Bound Protein Complexes. Nat. Prod. Rep. 22 (2005) 452-464
31. Loo J.A. Electrospray Ionization Mass Spectrometry: A Technology for Studying Noncovalent Macromolecular Complexes. Int. J. Mass Spectrom. 200 (2000) 175-186
32. Loo J.A., Berhane B., Kaddis C.S., Wooding K.M., Xie Y., Kaufman S.L., and Chernushevich I.V. Electrospray Ionization Mass Spectrometry and Ion Mobility Analysis of the 20S Proteasome Complex. J. Am. Soc. Mass Spectrom. 16 (2005) 998-1008
33. McKay A.R., Ruotolo B.T., Ilag L.L., and Robinson C.V. Mass Measurements of Increased Accuracy Resolve Heterogeneous Populations of Intact Ribosomes. J. Am. Chem. Soc. 128 (2006) 11433-11442
34. Pinkse M.W.H., Heck A.J.R., Rumpel K., and Pullen F. Probing Noncovalent Protein-Ligand Interactions of the cGMP-Dependent Protein Kinase Using Electrospray Ionizaiton Time of Flight Mass Spectrometry. J. Am. Soc. Mass Spectrom. 15 (2004) 1392-1399
35. Chevreux G., Potier N., Van Dorsselaer A., Bahloul A., Houdusse A., Wells A., and Sweeney H.L. Electrospray Ionization Mass Spectrometry Studies of Noncovalent Myosin VI Complexes Reveal a New Specific Calmodulin Binding Site. J. Am. Soc. Mass Spectrom. 16 (2005) 1367-1376
36. Chung E.W., Henriques D.A., Renzoni D., Morton C.J., Mulhern T.D., Pitkeathly M.C., Ladbury J.E., and Robinson C.V. Probing the Nature of Interactions in SH2 Binding Interfaces: Evidence from Electrospray Ionization Mass Spectrometry. Protein Sci. 8 (1999) 1962-1970
37. Rostom A.A., Tame J.R.H., Ladbury J.E., and Robinson C.V. Specificity and Interactions of the Protein OppA: Partitioning Solvent Binding Effects Using Mass Spectrometry. J. Mol. Biol. 296 (2000) 269-279
38. Liu J., Wu J., Wang X., and Cai Z. Study of the Phase I and Phase II Metabolism of a Mixture Containing Multiple Tanshinones Using Liquid Chromatography/Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 21 (2007) 2992-2998
39. Qian T., Cai Z., Wong R.N.S., and Jing Z. Liquid Chromatography/Mass Spectrometric Analysis of Rat Samples for In Vivo Metabolism and Pharmacokinetic Studies of Ginsenoside Rh2. Rapid Commun. Mass Spectrom. 19 (2005) 3549-3554
40. Honkakoski P., Arvela P., Juvonen R., Liang M.A., Kairaluoma M., and Pelkonen O. Human and Mouse Liver Coumarin 7-Hydroxylases Do Not Metabolize Warfarin In Vitro. Br. J. Clin. Pharmacol. 33 (1992) 313-317
41. Ufer M. Comparative Pharmacokinetics of Vitamin K Antagonists. Clin. Pharmacokinet. 44 (2005) 1227-1246
42. Lewis R.J., and Trager W.F. Warfarin Metabolism in Man: Identification of Metabolites in Urine. J. Clin. Invest. 49 (1970) 907-913
43. Yu B., Wu H., and Zhou P. The Interaction of Dyes, Drugs and Environmental Chemical Pollutants with Serum Albumin. Chemistry 68 (2005) 1-6
44. Henrotte V., Laurent S., Gabelica V., Vander Elst L., Depauw E., and Muller R.N. Investigation of Non-Covalent Interactions between Paramagnetic Complexes and Human Serum Albumin by Electrospray Mass Spectrometry. Rapid Commun. Mass Spectrom. 18 (2004) 1919-1924
45. Henrotte V., Vander Elst L., Laurent S., and Muller R.N. Comprehensive Investigation of the Non-Covalent Binding of MRI Contrast Agents with Human Serum Albumin. J. Biol. Inorg. Chem. 12 (2007) 929-937
46. Rich R.L., Day Y.S.N., Morton T.A., and Myszka D.G. High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE. Anal. Biochem. 296 (2001) 197-207
47. Benkestock K., Edlund P., and Roeraade J. Electrospray Ionization Mass Spectrometry as a Tool for Determination of Drug Binding Sites to Human Serum Albumin by Noncovalent Interaction. Rapid Commun. Mass Spectrom. 19 (2005) 1637-1643